Reich 2005.
| Methods | RCT Open 1997‐2001 |
|
| Participants | Number: 236 patients Age: meropenem med 44 range (18–70); piperacillin‐tazobactam 44 (20–63) |
|
| Interventions | meropenem 1grX3 versus piperacillin‐tazobactam 4.5grX3 |
|
| Outcomes | Clinical failure, fever duration | |
| Notes | MC Germany | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Adequate sequence generation? | Unclear risk | No description |
| Allocation concealment? | Low risk | Sealed envelopes attached to sequentially numbered patient documentation folders (opaque not mentioned) |
| Blinding? All outcomes | High risk | No blinding used |
| Incomplete outcome data addressed? All‐cause mortality | Unclear risk | Outcome not reported |
| Incomplete outcome data addressed? Treatment failure | High risk | 2% dropouts |
| Free of other bias? | Low risk | |